Synthesis and Cytotoxic Activity of Ethyl 2-Amino-1-Benzamido-4-Oxo-5-(2-Oxo-2-Arylethylidene)- 4,5-Dihydro-1H-Pyrrole-3-Carboxylates


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Recyclization of 5-aryl-2,3-dihydro-2-furandione 3-benzoylhydrazones (I) induced by cyanoacetic ester produced ethyl 2-amino-1-benzamido-4-oxo-5-(2-oxo-2-arylethylidene)-4,5-dihydro-1H-pyrrole-3-carboxylates (IIa-g). The biological activity of the synthesized compounds, which possessed low toxicities, was investigated. Ethyl 2-amino-1-benzamido-5-[2-(4-chlorophenyl)-2-oxoethylidene]-4-oxo-4,5-dihydro-1H-pyrrole-3-carboxylate (IIf) and the 5-[2-(3,4-dimethoxyphenyl)-2-oxoethylidene] analog (IIc) exhibited the greatest cytotoxicities against several connective-tissue tumor cell lines, namely, gastrointestinal stromal tumors (GISTs), osteosarcoma U2OS, and leiomyosarcoma SK-LMS-1. Ethyl 2-amino-1-benzamido-4-oxo-5-[2-oxo-2-(p-tolyl)ethylidene]-4,5-dihydro-1H-pyrrole-3-carboxylate (IIa) suppressed significantly tumor growth of GIST, LMS, and OS cell lines. Its activity against GIST cells at 10 μM was comparable with that of imatinib (1 μM) and, at lower concentrations (2.5 and 5 μM), with those of doxorubicin (0.25 μg/mL) and etoposide (40 μM), and exceeded significantly those of taxol (1 μM) and hydroxyurea (1 mM). The cytotoxicities of most of the studied compounds at 10 μM against SK-LMS-1 and U2OS cells in vitro were significantly greater than all reference drugs (doxorubicin, taxol, etoposide, etc.).

About the authors

S. S. Zykova

Perm Federal Penal Service Institute

Author for correspondence.
Email: zykova.sv@rambler.ru
Russian Federation, 125 Karpinskogo St., Perm, 614012

A. R. Galembikova

Kazan State Medical University

Email: zykova.sv@rambler.ru
Russian Federation, 49 Butlerova St., Kazan, Tatarstan, 420012

B. R. Ramazanov

Kazan State Medical University

Email: zykova.sv@rambler.ru
Russian Federation, 49 Butlerova St., Kazan, Tatarstan, 420012

T. F. Odegova

Perm State Pharmaceutical Academy

Email: zykova.sv@rambler.ru
Russian Federation, 2 Polevaya St., Perm, 614009

N. M. Igidov

Perm State Pharmaceutical Academy

Email: zykova.sv@rambler.ru
Russian Federation, 2 Polevaya St., Perm, 614009

M. A. Kiselev

Perm State Pharmaceutical Academy

Email: zykova.sv@rambler.ru
Russian Federation, 2 Polevaya St., Perm, 614009

S. V. Boichuk

Kazan State Medical University

Email: zykova.sv@rambler.ru
Russian Federation, 49 Butlerova St., Kazan, Tatarstan, 420012


Copyright (c) 2016 Springer Science+Business Media New York

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies